Literature DB >> 12644700

Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor.

Wen Xie1, Mei-Fei Yeuh, Anna Radominska-Pandya, Simrat P S Saini, Yoichi Negishi, Bobbie Sue Bottroff, Geraldine Y Cabrera, Robert H Tukey, Ronald M Evans.   

Abstract

Through a multiplex promoter spanning 218 kb, the phase II UDP-glucuronosyltransferase 1A (UGT1) gene encodes at least eight differently regulated mRNAs whose protein products function as the principal means to eliminate a vast array of steroids, heme metabolites, environmental toxins, and drugs. The orphan nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) were originally identified as sensors able to respond to numerous environmentally derived foreign compounds (xenobiotics) to promote detoxification by phase I cytochrome P450 genes. In this report, we show that both receptors can induce specific UGT1A isoforms including those involved in estrogen, thyroxin, bilirubin, and carcinogen metabolism. Transgenic mice expressing a constitutively active form of human PXR show markedly increased UGT activity toward steroid, heme, and carcinogens, enhanced bilirubin clearance, as well as massively increased steroid clearance. The ability of PXR and constitutive androstane receptor and their ligands to transduce both the phase I and phase II adaptive hepatic response defines a unique transcriptional interface that bridges the ingestion and metabolism of environmental compounds to body physiology.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12644700      PMCID: PMC153063          DOI: 10.1073/pnas.0438010100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

Review 1.  Characterization of human microsomal cytochrome P-450 enzymes.

Authors:  F P Guengerich
Journal:  Annu Rev Pharmacol Toxicol       Date:  1989       Impact factor: 13.820

2.  An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway.

Authors:  S A Kliewer; J T Moore; L Wade; J L Staudinger; M A Watson; S A Jones; D D McKee; B B Oliver; T M Willson; R H Zetterström; T Perlmann; J M Lehmann
Journal:  Cell       Date:  1998-01-09       Impact factor: 41.582

3.  Genetic inheritance of Gilbert's syndrome.

Authors:  P Bosma; J R Chowdhury; P H Jansen
Journal:  Lancet       Date:  1995-07-29       Impact factor: 79.321

4.  Differential down-regulation of the UDP-glucuronosyltransferase 1A locus is an early event in human liver and biliary cancer.

Authors:  C P Strassburg; M P Manns; R H Tukey
Journal:  Cancer Res       Date:  1997-07-15       Impact factor: 12.701

5.  Unexpected clinical remission of cholestasis after rifampicin therapy in patients with normal or slightly increased levels of gamma-glutamyl transpeptidase.

Authors:  E L Cançado; R M Leitão; F J Carrilho; A A Laudanna
Journal:  Am J Gastroenterol       Date:  1998-09       Impact factor: 10.864

6.  A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini.

Authors:  J K Ritter; F Chen; Y Y Sheen; H M Tran; S Kimura; M T Yeatman; I S Owens
Journal:  J Biol Chem       Date:  1992-02-15       Impact factor: 5.157

7.  SXR, a novel steroid and xenobiotic-sensing nuclear receptor.

Authors:  B Blumberg; W Sabbagh; H Juguilon; J Bolado; C M van Meter; E S Ong; R M Evans
Journal:  Genes Dev       Date:  1998-10-15       Impact factor: 11.361

8.  Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development.

Authors:  G W Smith; J M Aubry; F Dellu; A Contarino; L M Bilezikjian; L H Gold; R Chen; Y Marchuk; C Hauser; C A Bentley; P E Sawchenko; G F Koob; W Vale; K F Lee
Journal:  Neuron       Date:  1998-06       Impact factor: 17.173

9.  The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene.

Authors:  P Honkakoski; I Zelko; T Sueyoshi; M Negishi
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

10.  Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction.

Authors:  G Bertilsson; J Heidrich; K Svensson; M Asman; L Jendeberg; M Sydow-Bäckman; R Ohlsson; H Postlind; P Blomquist; A Berkenstam
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

View more
  97 in total

Review 1.  Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR.

Authors:  Antonia H Tolson; Hongbing Wang
Journal:  Adv Drug Deliv Rev       Date:  2010-08-17       Impact factor: 15.470

2.  Crystallographic analysis of murine constitutive androstane receptor ligand-binding domain complexed with 5alpha-androst-16-en-3alpha-ol.

Authors:  Jeremy Vincent; Li Shan; Ming Fan; Joseph S Brunzelle; Barry M Forman; Elias J Fernandez
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2004-12-24

Review 3.  Pregnane X receptor and natural products: beyond drug-drug interactions.

Authors:  Jeff L Staudinger; Xunshan Ding; Kristin Lichti
Journal:  Expert Opin Drug Metab Toxicol       Date:  2006-12       Impact factor: 4.481

4.  Identification of regulatory sites in the human PXR (NR1I2) promoter region.

Authors:  Kouichi Kurose; Shinobu Ikeda; Satoru Koyano; Masahiro Tohkin; Ryuichi Hasegawa; Jun-ichi Sawada
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

Review 5.  Evolution and function of the NR1I nuclear hormone receptor subfamily (VDR, PXR, and CAR) with respect to metabolism of xenobiotics and endogenous compounds.

Authors:  E J Reschly; Matthew D Krasowski
Journal:  Curr Drug Metab       Date:  2006-05       Impact factor: 3.731

Review 6.  Pregnane X receptor- and CYP3A4-humanized mouse models and their applications.

Authors:  Jie Cheng; Xiaochao Ma; Frank J Gonzalez
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

Review 7.  Hepatocyte nuclear factor 4alpha regulation of bile acid and drug metabolism.

Authors:  John Y L Chiang
Journal:  Expert Opin Drug Metab Toxicol       Date:  2009-02       Impact factor: 4.481

Review 8.  Alterations of chemotherapeutic pharmacokinetic profiles by drug-drug interactions.

Authors:  Sridhar Mani; Mohammed Ghalib; Imran Chaudhary; Sanjay Goel
Journal:  Expert Opin Drug Metab Toxicol       Date:  2009-02       Impact factor: 4.481

9.  Induction of bilirubin clearance by the constitutive androstane receptor (CAR).

Authors:  Wendong Huang; Jun Zhang; Steven S Chua; Mohammed Qatanani; Yunqing Han; Riccarda Granata; David D Moore
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-18       Impact factor: 11.205

10.  Induction of mouse UDP-glucuronosyltransferase mRNA expression in liver and intestine by activators of aryl-hydrocarbon receptor, constitutive androstane receptor, pregnane X receptor, peroxisome proliferator-activated receptor alpha, and nuclear factor erythroid 2-related factor 2.

Authors:  David B Buckley; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2009-01-14       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.